CN1078229A - Process and intermediates for the preparation of 2-substituted benzaldehydes - Google Patents
Process and intermediates for the preparation of 2-substituted benzaldehydes Download PDFInfo
- Publication number
- CN1078229A CN1078229A CN93102980A CN93102980A CN1078229A CN 1078229 A CN1078229 A CN 1078229A CN 93102980 A CN93102980 A CN 93102980A CN 93102980 A CN93102980 A CN 93102980A CN 1078229 A CN1078229 A CN 1078229A
- Authority
- CN
- China
- Prior art keywords
- alkyl
- formula
- phenyl
- compound
- reaction
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C251/00—Compounds containing nitrogen atoms doubly-bound to a carbon skeleton
- C07C251/72—Hydrazones
- C07C251/86—Hydrazones having doubly-bound carbon atoms of hydrazone groups bound to carbon atoms of six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C251/00—Compounds containing nitrogen atoms doubly-bound to a carbon skeleton
- C07C251/02—Compounds containing nitrogen atoms doubly-bound to a carbon skeleton containing imino groups
- C07C251/24—Compounds containing nitrogen atoms doubly-bound to a carbon skeleton containing imino groups having carbon atoms of imino groups bound to carbon atoms of six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
- C07C45/51—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by pyrolysis, rearrangement or decomposition
- C07C45/516—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by pyrolysis, rearrangement or decomposition involving transformation of nitrogen-containing compounds to >C = O groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C47/00—Compounds having —CHO groups
- C07C47/52—Compounds having —CHO groups bound to carbon atoms of six—membered aromatic rings
- C07C47/546—Compounds having —CHO groups bound to carbon atoms of six—membered aromatic rings polycyclic
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
Description
本发明涉及在合成药物活性试剂中制备有用中间体的新的中间体和方法。The present invention relates to novel intermediates and processes for the preparation of useful intermediates in the synthesis of pharmaceutically active agents.
2-取代的苯甲醛是制备药物活性化合物的有用的中间体,例如,一些作为白细胞三烯拮抗物并可用来治疗哮喘的化合物可以由具有下列通式(Ⅰa)的2-取代苯甲醛制得:2-Substituted benzaldehydes are useful intermediates for the preparation of pharmaceutically active compounds. For example, some compounds which are leukotriene antagonists and are useful in the treatment of asthma can be prepared from 2-substituted benzaldehydes having the general formula (Ia) :
其中in
Rx是(L)a-(CH2)b-(T)c-M;R x is (L)a-( CH2 ) b- (T) c -M;
a值为0或1;a value is 0 or 1;
b值为3至14;b value from 3 to 14;
c值为0或1;c value is 0 or 1;
L和T独立地是硫,氧,或CH2;L and T are independently sulfur, oxygen, or CH2 ;
M是C1-4烷基,乙炔基,三氟甲基,异丙烯基,呋喃基,噻吩基,环己基或任意地被溴、氯、CF3、C1-4烷基、C1-4烷氧基、甲硫基或三氟甲硫基单取代的苯基;M is C 1-4 alkyl, ethynyl, trifluoromethyl, isopropenyl, furyl, thienyl, cyclohexyl or optionally bromo, chloro, CF 3 , C 1-4 alkyl, C 1- 4 alkoxy, methylthio or trifluoromethylthio monosubstituted phenyl;
R2和A可独立地选自H,CF3,C1-4烷基,C1-4烷氧基,F,Cl,Br,I,OH,NO2或NH2;R 2 and A can be independently selected from H, CF 3 , C 1-4 alkyl, C 1-4 alkoxy, F, Cl, Br, I, OH, NO 2 or NH 2 ;
或者R1和A是H,R2是(L)a-(CH2)b-(T)c-M,其中a,b,c,L,T和M的定义与前相同。Or R1 and A are H, and R2 is (L) a- ( CH2 ) b- (T) c -M, wherein a, b, c, L, T and M are as defined above.
这类化合物已在例如美国专利4,820,719,美国专利4,874,792和欧洲专利EP-A0,296,732中被公开。这些文献作为参考文献并入本文。因此,文献中已报导了两种制备2-取代苯甲醛的一般方法:1)在钯催化作用下将取代的1-炔基化合物对2-卤代苯甲醛加成,导致偶联而直接得到2-(1-炔基)苯甲醛;2)把2-甲氧基苯甲酸转化为2-(2-甲氧基苯基)-4,4-二甲基-恶唑啉,然后用烷基或芳烷基格氏试剂处理,以制备出相应的2-(2-烷基苯基)-4,4-二甲基-恶唑啉或2-(2-芳基烷基苯基)-4,4-二甲基-恶唑啉(然后用碘甲烷处理2-取代的恶唑啉,用硼氢化钠还原,再进行酸水解即产生相应的2-取代苯甲醛)。后一种方法是基于Meyer等人发现的方法,可参看J.Org.Chem.,43,1372(1978年)。类似的制备2-取代苯甲醛的方法也曾被Perchmock等人所公开,可参看J.Med.Chem.,28,1145(1985年)。一般,这些方法是采用通过其官能团置换芳环上取代基的试剂。Such compounds are disclosed, for example, in U.S. Patent 4,820,719, U.S. Patent 4,874,792 and European Patent EP-A 0,296,732. These documents are incorporated herein by reference. Thus, two general methods for the preparation of 2-substituted benzaldehydes have been reported in the literature: 1) Palladium-catalyzed addition of substituted 1-alkynyl compounds to 2-halobenzaldehydes, leading to coupling to directly obtain 2-(1-alkynyl)benzaldehyde; 2) convert 2-methoxybenzoic acid into 2-(2-methoxyphenyl)-4,4-dimethyl-oxazoline, and then use alkane base or aralkyl Grignard reagents to prepare the corresponding 2-(2-alkylphenyl)-4,4-dimethyl-oxazoline or 2-(2-arylalkylphenyl) -4,4-Dimethyl-oxazoline (the 2-substituted oxazoline is then treated with iodomethane, reduced with sodium borohydride, and then subjected to acid hydrolysis to produce the corresponding 2-substituted benzaldehyde). The latter method is based on the method discovered by Meyer et al., cf. J. Org. Chem., 43, 1372 (1978). A similar method for the preparation of 2-substituted benzaldehydes has also been disclosed by Perchmock et al., see J. Med. Chem., 28, 1145 (1985). Generally, these methods employ reagents that displace substituents on aromatic rings through their functional groups.
使芳环发生亲核取代从而在芳环的邻位加入一个取代基的方法也是已知的。Org.Reaction26,43-61(1979年)报导某些含有氮杂原子并连接在苯环上的官能团能使苯环对锂化反应变得稳定,特别是在邻位,锂化的位置然后可用适当的亲电试剂处理而发生取代反应。已报导的对于达到这一目的特别有效的官能团是一或二烷基酰胺类,胺类,N,N-二烷基腙类,咪唑啉类和恶唑啉类。De Silva等人在Tetrahedron Lett.,5107(1978年)中报导用仲丁基锂和二异丙基胺在苯甲酰胺的邻位进行锂化反应。Trecourt等人在J.Org.Chem.,53,1367(1988年)中报导用甲基锂和催化量的二异丙胺在2-甲氧基吡啶的邻位进行锂化反应。但据报导芳基碳亚胺类则由于它们容易在碳亚胺位置发生反应以及α-去质子化反应而只有有限的合成适用性。参看Org.Reactions,26,57-58(1979年)。Zeigler等在J.Org.Chem.,41,1564(1976年)杂志上报导,如果有邻近的醚取代基存在,则芳基碳亚胺类也可被诱导而发生邻位的锂化反应。Methods are also known for nucleophilic substitution of aromatic rings to add a substituent in the ortho position of the aromatic ring. Org.Reaction26, 43-61 (1979) reported that certain functional groups containing nitrogen heteroatoms and attached to the benzene ring can stabilize the benzene ring for lithiation reactions, especially in the ortho position, and the lithiated position can then be used Treatment with an appropriate electrophile results in a substitution reaction. Functional groups that have been reported to be particularly effective for this purpose are mono- or dialkylamides, amines, N,N-dialkylhydrazones, imidazolines and oxazolines. De Silva et al. in Tetrahedron Lett., 5107 (1978) reported lithiation with sec-butyllithium and diisopropylamine in the ortho position of benzamide. Trecourt et al. in J. Org. Chem., 53, 1367 (1988) report the lithiation in the ortho position of 2-methoxypyridine with methyllithium and a catalytic amount of diisopropylamine. However, arylcarbimides have been reported to have limited synthetic applicability due to their ease of reaction at the carboimide position and α-deprotonation reactions. See Org. Reactions, 26, 57-58 (1979). Zeigler et al. reported in J.Org.Chem., 41, 1564 (1976) that arylcarboimides can also be induced to lithiate in the ortho position if adjacent ether substituents are present.
此外,已有报导,如果甲基是处在苯甲酰胺类,2-苯基咪唑啉类和2-苯基恶唑啉类的邻位,则甲基也可被锂化。例如,Watanabe等人在J.Org.Chem.,49,742(1984年)中报导,在异香豆素类的合成中经过邻位甲苯酰胺扩展侧链;Gschwend等人在J.Org.Chem.,40,2008(1975年)中报导,经由2-(邻-甲苯基)恶唑啉的锂化来延伸苄基侧链;还有Houlihan在美国专利4,100,165中报导,二锂化的2-(邻-甲苯基)咪唑啉可与酯和酰卤类发生缩合反应。In addition, it has been reported that the methyl group can also be lithiated if it is in the ortho position of benzamides, 2-phenylimidazolines and 2-phenyloxazolines. For example, Watanabe et al reported in J.Org.Chem., 49,742 (1984) that in the synthesis of isocoumarins the side chain was extended through ortho-toluamide; Gschwend et al. in J.Org.Chem. , 40, 2008 (1975), reported that the benzyl side chain was extended by lithiation of 2-(o-tolyl)oxazoline; also Houlihan reported in U.S. Patent 4,100,165 that dilithiation The 2-(o-tolyl) imidazoline can undergo condensation reaction with esters and acyl halides.
现行的合成本发明中的2-取代苯甲醛的方法都使用昂贵的试剂或多步反应方法,这使它们在工业规模制备2-取代苯甲醛中没有吸引力。因此,需要有另外的有效制备2-取代苯甲醛类的方法。The current methods for synthesizing 2-substituted benzaldehydes in the present invention all use expensive reagents or multi-step reaction methods, which makes them unattractive in the industrial scale preparation of 2-substituted benzaldehydes. Therefore, there is a need for alternative methods of efficiently preparing 2-substituted benzaldehydes.
本发明的一个目的是提供一种新的和有效的制备具有下式(Ⅰb)化合物的方法:It is an object of the present invention to provide a novel and efficient process for the preparation of compounds of the formula (Ib):
式中:In the formula:
R1是CH2CH2-(L1)p-(CH2)q-(L2)r-CH2-(T)s-Z; R1 is CH2CH2- ( L1 ) p- ( CH2 ) q- ( L2 ) r - CH2- (T) s -Z;
L1和L2独立地是CH2CH2,CH=CH或C≡C;L 1 and L 2 are independently CH 2 CH 2 , CH=CH or C≡C;
q是0至8;q is 0 to 8;
p,r和s独立地是0或1;p, r and s are independently 0 or 1;
T是O,S,CH2,CH=CH,C≡C;和T is O, S, CH2 , CH=CH, C≡C; and
Z是C1-4烷基,乙炔基,三氟甲基,异丙烯基,呋喃基,噻吩基,环己基或任意地被CF3、C1-4烷基、C1-4烷氧基、甲硫基或三氟甲硫基单取代的苯基;Z is C 1-4 alkyl, ethynyl, trifluoromethyl, isopropenyl, furyl, thienyl, cyclohexyl or optionally replaced by CF 3 , C 1-4 alkyl, C 1-4 alkoxy , methylthio or trifluoromethylthio monosubstituted phenyl;
R2和A独立地是H,CF3,C1-4烷基,F,Cl,Br或I。R 2 and A are independently H, CF 3 , C 1-4 alkyl, F, Cl, Br or I.
本发明的一个特征是制备下式化合物的方法:A feature of the invention is a process for the preparation of compounds of the formula:
式中A,R1,R2,L1,L2,q,p,r,s,T和Z的定义与前面式(Ⅰb)的相同;In the formula, the definitions of A, R 1 , R 2 , L 1 , L 2 , q, p, r, s, T and Z are the same as those of the preceding formula (Ib);
该方法包括把式(Ⅲ)化合物与一种碱和式(Ⅳ)化合物反应,然后用酸处理反应的产物;The process comprises reacting a compound of formula (III) with a base and a compound of formula (IV) and then treating the reaction product with an acid;
式中:In the formula:
R2和A的定义与上面式(Ⅰb)的相同;The definitions of R2 and A are the same as those of formula (Ib) above;
R3是C1-6烷基,C3-6环烷基,(CH2)t苯基或N(R′)2;R 3 is C 1-6 alkyl, C 3-6 cycloalkyl, (CH 2 ) t phenyl or N(R') 2 ;
R′是C1-6烷基,C3-6环烷基或(CH2)t苯基;R' is C 1-6 alkyl, C 3-6 cycloalkyl or (CH 2 ) t phenyl;
t值为0或1;t value is 0 or 1;
式中:In the formula:
L1,L2,p,q,r,s,T和Z的定义与上面式(Ⅰb)的相同,X是一个可置换的基团。L 1 , L 2 , p, q, r, s, T and Z are as defined in the above formula (Ib), and X is a substitutable group.
本发明的另一个特征是提供下式(Ⅱ)的新的中间体:Another feature of the present invention is to provide novel intermediates of the following formula (II):
式中:In the formula:
R1,R2和A的定义与式(Ⅰb)中的相同;R 1 , R 2 and A have the same definitions as in formula (Ib);
R3是C1-6烷基,C3-6环烷基,(CH2)t苯基或N(R′)2;R 3 is C 1-6 alkyl, C 3-6 cycloalkyl, (CH 2 ) t phenyl or N(R') 2 ;
R′是C1-6烷基,C3-6环烷基或(CH2)t苯基;R' is C 1-6 alkyl, C 3-6 cycloalkyl or (CH 2 ) t phenyl;
t值为0或1。The t value is 0 or 1.
本发明的另一特征是提供一种制备式(Ⅱ)的新中间体的方法,它包括把式(Ⅲ)的化合物Another feature of the present invention is to provide a method for the preparation of new intermediates of formula (II), which comprises the compound of formula (III)
式中A,R2和R3的定义与式(Ⅱ)的相同,与一种碱和式(Ⅳ)化合物进行反应,In the formula, A, R 2 and R 3 are defined the same as those of formula (II), reacting with a base and the compound of formula (IV),
式中L1、L2、p、q、r、s、T和Z的定义与前面式(Ⅰb)中的相同,X是一个可置换的基团。The definitions of L 1 , L 2 , p, q, r, s, T and Z in the formula are the same as in the preceding formula (Ib), and X is a substitutable group.
本发明再一个特征是提供一种经过改进的制备式(Ⅱ)化合物的方法,它包括在加碱之前往反应混合物中加入催化量的一种有机胺。Another feature of the invention is to provide an improved process for the preparation of compounds of formula (II) which comprises adding to the reaction mixture a catalytic amount of an organic amine prior to the addition of the base.
本发明还有另一个特征是提供一种经过改进的制备式(Ⅱ)化合物的方法,它包括往反应混合物中加入烷氧化钠或烷氧化钾。Still another feature of the present invention is to provide an improved process for the preparation of compounds of formula (II) which comprises adding sodium alkoxide or potassium alkoxide to the reaction mixture.
本发明的另一个特征是提供一种经过改进的制备式(Ⅱ)化合物的方法,它包括在特定的温度范围内进行上述反应。Another feature of the present invention is to provide an improved process for the preparation of compounds of formula (II) which comprises carrying out the above reaction within a specified temperature range.
本发明公开了有用的中间体和一种制备式(Ⅰb)化合物的方法:The present invention discloses useful intermediates and a process for the preparation of compounds of formula (Ib):
式中:In the formula:
R1是CH2CH2-(L1)p-(CH2)q-(L2)r-CH2-(T)s-Z; R1 is CH2CH2- ( L1 ) p- ( CH2 ) q- ( L2 ) r - CH2- (T) s -Z;
L1和L2独立地是CH2CH2,CH=CH或C≡C;L 1 and L 2 are independently CH 2 CH 2 , CH=CH or C≡C;
q值为0至8;q value from 0 to 8;
p,r和s独立地是0或1;p, r and s are independently 0 or 1;
T是O,S,CH2,CH=CH,C≡C;T is O, S, CH2 , CH=CH, C≡C;
Z是C1-4烷基,乙炔基,三氟甲基,异丙烯基,呋喃基,噻吩基,环己基或任意地被CF3、C1-4烷基、C1-4烷氧基、甲硫基或三氟甲硫基单取代的苯基;Z is C 1-4 alkyl, ethynyl, trifluoromethyl, isopropenyl, furyl, thienyl, cyclohexyl or optionally replaced by CF 3 , C 1-4 alkyl, C 1-4 alkoxy , methylthio or trifluoromethylthio monosubstituted phenyl;
R2和A独立地是H,CF3,C1-4烷基,F,Cl,Br或I;R 2 and A are independently H, CF 3 , C 1-4 alkyl, F, Cl, Br or I;
该方法包括将式(Ⅲ)化合物与一种碱和式(Ⅳ)化合物反应,然后用酸处理反应产物,式(Ⅲ)是:The method comprises reacting a compound of formula (III) with a base and a compound of formula (IV) and then treating the reaction product with an acid, formula (III) being:
式中In the formula
R2和A的定义与前相同;The definitions of R2 and A are the same as before;
R3是C1-6烷基,C3-6环烷基,(CH2)t苯基或N(R′)2;R 3 is C 1-6 alkyl, C 3-6 cycloalkyl, (CH 2 ) t phenyl or N(R') 2 ;
R′是C1-6烷基,C3-6环烷基或(CH2)t苯基;R' is C 1-6 alkyl, C 3-6 cycloalkyl or (CH 2 ) t phenyl;
t值为0或1;t value is 0 or 1;
式(Ⅳ)是:Formula (Ⅳ) is:
式中In the formula
L1、L2、p、q、r、s、T和Z的定义与前相同;和L 1 , L 2 , p, q, r, s, T and Z have the same definitions as before; and
X是一个可置换的基团。X is a displaceable group.
此外,本发明公开了下式(Ⅱ)的新的中间体:In addition, the present invention discloses new intermediates of the following formula (II):
式中In the formula
R1是CH2CH2-(L1)p-(CH2)q-(L2)r-CH2-(T)s-Z; R1 is CH2CH2- ( L1 ) p- ( CH2 ) q- ( L2 ) r - CH2- (T) s -Z;
L1和L2独立地是CH2CH2,CH=CH或C≡C;L 1 and L 2 are independently CH 2 CH 2 , CH=CH or C≡C;
q值为0至8;q value from 0 to 8;
p,r和s独立地是0或1;p, r and s are independently 0 or 1;
T是O,S,CH2,CH=CH,C≡C;T is O, S, CH2 , CH=CH, C≡C;
Z是C1-4烷基,乙炔基,三氟甲基,异丙烯基,呋喃基,噻吩基,环己基或者任意地被CF3、C1-4烷基、C1-4烷氧基、甲硫基或三氟甲硫基单取代的苯基;Z is C 1-4 alkyl, ethynyl, trifluoromethyl, isopropenyl, furyl, thienyl, cyclohexyl or optionally replaced by CF 3 , C 1-4 alkyl, C 1-4 alkoxy , methylthio or trifluoromethylthio monosubstituted phenyl;
R2和A独立地是H,CF3,C1-4烷基,F,Cl,Br或I;R 2 and A are independently H, CF 3 , C 1-4 alkyl, F, Cl, Br or I;
R3是C1-6烷基,C3-6环烷基,(CH2)t苯基或N(R′)2;R 3 is C 1-6 alkyl, C 3-6 cycloalkyl, (CH 2 ) t phenyl or N(R') 2 ;
R′是C1-6烷基,C3-6环烷基或(CH2)t苯基;R' is C 1-6 alkyl, C 3-6 cycloalkyl or (CH 2 ) t phenyl;
t值为0或1。The t value is 0 or 1.
合适的Z是苯基,L1和L2是CH2CH2。Suitably Z is phenyl and L1 and L2 are CH2CH2 .
合适的R3是叔丁基。Suitable R3 is tert-butyl.
合适的p,r和s值是1。A suitable p, r and s value is 1.
合适的q值是0至2。Suitable values for q are 0 to 2.
合适的T是CH2或C≡C。Suitable T is CH2 or C≡C.
一种优选的化合物是N-[2-(8-苯基辛基)苯基亚甲基]-1,1-二甲基乙胺。A preferred compound is N-[2-(8-phenyloctyl)phenylmethylene]-1,1-dimethylethylamine.
式(Ⅱ)的新中间体是用这样一种方法来制备的,包括把下列式(Ⅲ)化合物:Novel intermediates of formula (II) are prepared by a process which involves the following compound of formula (III):
式中In the formula
R2和A独立地是H,CF3,C1-4烷基,F,Cl,Br或I;R 2 and A are independently H, CF 3 , C 1-4 alkyl, F, Cl, Br or I;
R3是C1-6烷基,C3-6环烷基,(CH2)t苯基或N(R′)2;R 3 is C 1-6 alkyl, C 3-6 cycloalkyl, (CH 2 ) t phenyl or N(R') 2 ;
R′是C1-6烷基,C3-6环烷基或(CH2)t苯基;R' is C 1-6 alkyl, C 3-6 cycloalkyl or (CH 2 ) t phenyl;
t值为0或1;t value is 0 or 1;
与一种碱和一种式(Ⅳ)化合物进行反应:Reaction with a base and a compound of formula (IV):
式中In the formula
L1和L2独立地是CH2CH2,CH=CH或C≡C;L 1 and L 2 are independently CH 2 CH 2 , CH=CH or C≡C;
q值是0至8;q value is 0 to 8;
p,r和s独立地是0或1;p, r and s are independently 0 or 1;
T是O,S,CH2,CH=CH,C≡C;T is O, S, CH2 , CH=CH, C≡C;
Z是C1-4烷基,乙炔基,三氟甲基,异丙烯基,呋喃基,噻吩基,环己基或者任意地被CF3、C1-4烷基、C1-4烷氧基、甲硫基或三氟甲硫基单取代的苯基;和Z is C 1-4 alkyl, ethynyl, trifluoromethyl, isopropenyl, furyl, thienyl, cyclohexyl or optionally replaced by CF 3 , C 1-4 alkyl, C 1-4 alkoxy , methylthio or trifluoromethylthio monosubstituted phenyl; and
X是一个可置换的基团。X is a displaceable group.
在一优选实例中,本发明公开了一种制备式(Ⅰb)化合物的方法,它包括把式Ⅲ)的化合物与一种碱和一种式(Ⅳ)化合物进行反应,然后用酸处理反应混合物。于是,在该优选实施例中,整个转化是在一个单一反应容器中完成的,无需分离中间产物。这一方法使用容易得到的原料并且以有效的产率,用最少数的反应步骤来进行。In a preferred embodiment, the present invention discloses a method for preparing a compound of formula (Ib), which comprises reacting a compound of formula III) with a base and a compound of formula (IV), and then treating the reaction mixture with an acid . Thus, in this preferred embodiment, the entire conversion is accomplished in a single reaction vessel without isolation of intermediate products. This method uses readily available starting materials and is performed in efficient yields with a minimum number of reaction steps.
式(Ⅲ)化合物是腙类和亚胺类,或西佛碱,通常可用本专业中常用的任意一种制备这类化合物的方法来制备。一种制备亚胺类化合物的方法包括把式(Ⅴ)化合物The compounds of formula (III) are hydrazones and imines, or Schiff's bases, and can generally be prepared by any of the methods commonly used in the art for the preparation of such compounds. A kind of method for preparing imine compound comprises formula (Ⅴ) compound
与一种式R3-NH2的胺或肼进行反应。这反应通常是在一种非水溶剂中把两种反应物混合,并可加热来进行的。必要时可用脱水剂来促使反应进行完全。普通的脱水剂是:例如,分子筛或硫酸镁。另外,也可以用一种适当的溶剂诸如苯或甲苯,把反应中产生的水通过恒沸蒸馏的方法来达到脱水目的。基团R3是C1-6烷基,C3-6环烷基,苄基,苯基或N(R′)2。环己基胺,叔丁胺,苯胺和N,N-二甲基肼是合适的试剂,最好是用叔丁胺。Reaction with an amine or hydrazine of formula R3 - NH2 . This reaction is usually carried out by mixing the two reactants in a non-aqueous solvent, which may be heated. A dehydrating agent can be used to complete the reaction if necessary. Common dehydrating agents are: eg molecular sieves or magnesium sulfate. In addition, a suitable solvent such as benzene or toluene can also be used to dehydrate the water produced in the reaction by azeotropic distillation. The group R3 is C1-6 alkyl, C3-6 cycloalkyl, benzyl, phenyl or N(R') 2 . Cyclohexylamine, t-butylamine, aniline and N,N-dimethylhydrazine are suitable reagents, preferably t-butylamine.
由式(Ⅳ)给出的亲电试剂,可用通常的方法,诸如在美国专利4,820,719号,美国专利4,874,792号,欧洲专利申请0296732号和Perchanock等人J.Med.Chem.,28,1145(1985年)中公开的方法来制备,它们作为参考文献并入本文。亲电试剂的X部分代表一个可置换的基团,它可以是能被由式(Ⅲ)化合物制备的碳亲核体所置换的任何基团。有许多可置换的基团是合适的,诸如烷基和芳基磺酸酯,烷基和芳基烷基醋酸酯,苯甲酸酯和卤素。这类基团的代表有Cl,Br,I,R4SO3和R4CO2,其中R4是可被1-5个氟原子取代的C1-4烷基,或可被一或两个卤素、C1-4烷基、C1-4烷氧基或硝基取代的苯基。代表性的可置换基团有甲苯磺酸酯、溴-苯磺酸酯、硝基苯磺酸酯、甲磺酸酯、三氟甲磺酸酯、醋酸酯、氯代醋酸酯、三氟醋酸酯、苯甲酸酯、溴苯甲酸酯、氯苯甲酸酯、硝基苯甲酸酯,氯,溴和碘等基团,优选氯和溴,特别优选氯。The electrophile given by the formula (IV) can be used in the usual way, such as in U.S. Patent No. 4,820,719, U.S. Patent No. 4,874,792, European Patent Application No. 0296732 and Perchanock et al. J.Med. Chem., 28, 1145 (1985), which are incorporated herein by reference. The X moiety of the electrophile represents a displaceable group which may be any group capable of being displaced by a carbon nucleophile prepared from a compound of formula (III). A number of substitutable groups are suitable, such as alkyl and aryl sulfonates, alkyl and arylalkyl acetates, benzoates and halides. Representatives of such groups are Cl, Br, I, R 4 SO 3 and R 4 CO 2 , wherein R 4 is C 1-4 alkyl which may be substituted by 1-5 fluorine atoms, or may be substituted by one or two A halogen, C 1-4 alkyl, C 1-4 alkoxy or nitro substituted phenyl. Representative displaceable groups are tosylate, bromo-benzenesulfonate, nitrobenzenesulfonate, mesylate, triflate, acetate, chloroacetate, trifluoroacetic acid groups such as ester, benzoate, bromobenzoate, chlorobenzoate, nitrobenzoate, chlorine, bromine and iodine, preferably chlorine and bromine, particularly preferably chlorine.
一般,如果在前体中不存在X基团,则式(Ⅳ)化合物中的X基团可由相应的醇通过与适当的酰卤,酸酐,磺酰卤或适当的卤化试剂进行反应而制得。典型的这类试剂有甲苯磺酰氯,溴苯磺酰氯,硝基苯磺酰氯,甲磺酰氯,乙酰氯,氯代乙酰氯,三氟乙酸酐,苯甲酰氯,溴苯甲酰氯,氯苯甲酰氯,硝基苯甲酰氯,草酰氯或草酰溴,氢氯酸,氢溴酸,氢碘酸,三溴化磷,三氯化磷,三氯氧磷和含有三苯基膦的四溴化碳。通式HO-CH2-(L1)p-(CH2)q-(L2)r-CH2-(T)s-Z的化合物,其中的T是CH2,L1或L2是CH2CH2,Z是C1-4烷基或苯基时,一般都可从市场上买到。而其中的T是O,S或C≡C的那些化合物可以在一种适宜碱存在下通过把化合物H-T-Z与结构为X-CH2-(L1)p-(CH2)q-(L2)r-CH2-X的化合物反应而制得,其中X,L1,L2,T,p,q和r的定义与前相同。T是CH=CH的化合物可以用T是C≡C的化合物进行部分氢化而制得,例如用Lindlar催化剂或5%钯/BaSO4催化剂和氢进行氢化。用钯催化剂,例如5%钯/炭催化剂进行氢化时,产生T是CH2的化合物。当L1或L2是C≡C或CH=CH时,得到的产物可随后还原而产生L1或L2是CH=CH或CH2CH2的产物。例如,1-溴-7苯基庚烷可由1,5-二溴戊烷和苯基乙炔在正丁基锂存在下反应,然后用氢和钯催化剂还原而制得。在另一个实例中,1-溴或1-氯-7-苯基庚烷可由苄基卤化镁与1,6-二溴己烷或1-溴-6-氯己烷在铜参与下偶合而制得。In general, if the X group is not present in the precursor, the X group in the compound of formula (IV) can be prepared from the corresponding alcohol by reaction with the appropriate acid halide, acid anhydride, sulfonyl halide or suitable halogenating reagent . Typical of such reagents are toluenesulfonyl chloride, bromobenzenesulfonyl chloride, nitrobenzenesulfonyl chloride, methanesulfonyl chloride, acetyl chloride, chloroacetyl chloride, trifluoroacetic anhydride, benzoyl chloride, bromobenzoyl chloride, chlorobenzoyl chloride Acyl chloride, nitrobenzoyl chloride, oxalyl chloride or oxalyl bromide, hydrochloric acid, hydrobromic acid, hydroiodic acid, phosphorus tribromide, phosphorus trichloride, phosphorus oxychloride, and tetrabromide containing triphenylphosphine carbonized. A compound of the general formula HO-CH 2 -(L 1 ) p -(CH 2 ) q -(L 2 ) r -CH 2 -(T) s -Z, wherein T is CH 2 , and L 1 or L 2 is When CH 2 CH 2 , Z is C 1-4 alkyl or phenyl, they are generally commercially available. Those compounds in which T is O, S or C≡C can be obtained by combining the compound HTZ with the structure X-CH 2 -(L 1 ) p -(CH 2 ) q -(L 2 ) in the presence of a suitable base ) r -CH 2 -X compound reaction and prepared, wherein X, L 1 , L 2 , T, p, q and r are defined the same as before. Compounds where T is CH=CH can be prepared by partial hydrogenation of compounds where T is C≡C, for example with Lindlar catalyst or 5% palladium/BaSO 4 catalyst and hydrogen. Hydrogenation with a palladium catalyst, such as 5% palladium on charcoal, yields compounds where T is CH2 . When L1 or L2 is C≡C or CH=CH, the resulting product can be subsequently reduced to give a product where L1 or L2 is CH=CH or CH2CH2 . For example, 1-bromo-7-phenylheptane can be prepared by reacting 1,5-dibromopentane and phenylacetylene in the presence of n-butyllithium, followed by reduction with hydrogen and a palladium catalyst. In another example, 1-bromo or 1-chloro-7-phenylheptane can be prepared by coupling benzylmagnesium halide with 1,6-dibromohexane or 1-bromo-6-chlorohexane in the presence of copper be made of.
式(Ⅲ)的碳亚胺的烷基化反应可通过把式(Ⅲ)化合物的邻位甲基用强碱去质子化来引发反应。由于金属化的中间体对水是活泼的,所以活化反应要在一种惰性的干燥气体,诸如氮或氩气中进行,虽然也可在干燥的空气中进行。The alkylation of carboimides of formula (III) can be initiated by deprotonating the ortho-methyl group of the compound of formula (III) with a strong base. Since the metallized intermediate is reactive towards water, the activation reaction is carried out under an inert dry gas such as nitrogen or argon, although dry air can also be carried out.
活化反应是在非质子溶剂中进行的,适合于这一反应的溶剂是对强碱没有反应活性的普通的脂肪或芳香烃溶剂。这类溶剂的代表有乙醚,四氢呋喃,二恶烷,甲苯,苯,戊烷,己烷,石油醚以及它们的混合物。其中优选乙醚,二恶烷和四氢呋喃,特别优选四氢呋喃。The activation reaction is carried out in an aprotic solvent. Solvents suitable for this reaction are common aliphatic or aromatic hydrocarbon solvents which are not reactive to strong bases. Representative of such solvents are diethyl ether, tetrahydrofuran, dioxane, toluene, benzene, pentane, hexane, petroleum ether and mixtures thereof. Among them, diethyl ether, dioxane and tetrahydrofuran are preferred, and tetrahydrofuran is particularly preferred.
邻位甲基的去质子化反应需要足够强的碱。任何一种能够进行这样的去质子化反应,同时又不会引起明显副反应的碱都是合适的,典型的这类碱有碱金属烷基化物,碱金属胺化物,或碱金属芳基化物。这类碱的代表有正丁基锂,仲丁基锂,甲基锂,苯基锂,二异丙基胺化锂,二乙基胺化锂或氨基锂,或这类物质的相应的钠盐或钾盐。烷基锂试剂是特别合适的。优选正丁基锂和二异丙胺化锂。最初用的碱金属可交换成别的金属,例如别的碱金属,铜、镁或锌,这也在本发明的范围内。用稍过量的碱,诸如过量1%至25%,以保证金属化反应完全,常常是有帮助的。大约一摩尔当量通常是满意的。对于本专业熟练的技术人员来说,显然知道上述碱中有一些,例如碱金属烷基化物或芳基化物,可能与碳亚胺分子中的卤素取代基是不相容的,这时用别的碱,诸如二异丙胺化锂,将是更合适的。The deprotonation reaction of the ortho-methyl group requires a sufficiently strong base. Any base capable of carrying out such a deprotonation reaction without causing significant side reactions is suitable. Typical such bases are alkali metal alkyls, alkali metal amides, or alkali metal arylates. . Representative of such bases are n-butyllithium, sec-butyllithium, methyllithium, phenyllithium, lithium diisopropylamide, lithium diethylamide or lithium amide, or the corresponding sodium of such substances salt or potassium salt. Alkyllithium reagents are particularly suitable. Preference is given to n-butyllithium and lithium diisopropylamide. It is also within the scope of the invention that the alkali metal initially used may be exchanged for another metal, such as another alkali metal, copper, magnesium or zinc. It is often helpful to use a slight excess of base, such as a 1% to 25% excess, to ensure complete metallation. About one molar equivalent is usually satisfactory. It will be apparent to those skilled in the art that some of the above bases, such as alkali metal alkyls or arylates, may be incompatible with the halogen substituents in the carboimide molecule, and other A base such as lithium diisopropylamide would be more suitable.
式(Ⅲ)化合物与碱的反应是将两种反应物混合而进行的,反应应在足够高的温度下进行,该温度既能使碱在邻位甲基上引起去质子化,但又不能太高而引起有害的副反应。因此最佳的温度将取决于所用的碱和亚胺反应物。如果所用的碱是二烷胺化锂,反应典型地是在-20℃至60℃之间进行;反应最好是在大约-10°至40°之间进行。The reaction of the compound of formula (Ⅲ) with the base is carried out by mixing the two reactants, and the reaction should be carried out at a temperature high enough that the base can cause deprotonation on the ortho-position methyl group, but cannot Too high to cause harmful side effects. The optimum temperature will therefore depend on the base and imine reactant used. If the base used is lithium dialkylamide, the reaction is typically carried out at a temperature between -20°C and 60°C; preferably the reaction is carried out at a temperature between about -10° and 40°.
已经发现,当反应在大约15°至大约35℃之间进行时,能得到令人惊讶的改进了的产率。典型地,当强碱与具有对亲核进攻敏感的部分(例如碳亚胺功能团)的化合物反应时,反应是在大约0℃或更低的温度下进行。较低的温度相信能够防止不希望的副反应发生,例如碱本身或通过碱的作用产生的负离子对活泼的碳亚胺官能团的亲核进攻。意外的是,用某些碱,诸如正丁基锂加上催化量的二异丙胺或二环己基胺,通过在大约15℃至大约35℃把碱加到碳亚胺中,可使副反应减至最小并使产率增加。反应在大约20℃至大约30℃之间进行是特别合适的。高于55℃的温度一般会导致不希望的副反应的增多。It has been found that surprisingly improved yields are obtained when the reaction is carried out at a temperature between about 15° and about 35°C. Typically, when a strong base is reacted with a compound having a moiety susceptible to nucleophilic attack, such as a carboimide functionality, the reaction is carried out at a temperature of about 0°C or lower. The lower temperature is believed to prevent undesired side reactions such as nucleophilic attack of the active carboimide functional group by the base itself or by negative ions generated through the action of the base. Surprisingly, with certain bases, such as n-butyllithium plus a catalytic amount of diisopropylamine or dicyclohexylamine, by adding the base to the carboimide at about 15°C to about 35°C, the side reaction Minimize and increase yield. It is particularly suitable to conduct the reaction at a temperature between about 20°C and about 30°C. Temperatures above 55°C generally lead to increased unwanted side reactions.
典型做法是在金属化反应完成时加入亲电试剂X-CH2-(L1)p-(CH2)q-(L2)r-CH2-(T)s-Z。虽然可以加入纯净的亲电试剂,但更方便的是把它溶于用来形成金属化中间体的溶剂中再加入。然后把反应物搅拌15分钟至大约24小时。Typically, the electrophile X- CH2- ( L1 ) p- ( CH2 ) q- ( L2 ) r - CH2- (T) s -Z is added at the completion of the metallation reaction. Although it is possible to add the electrophile neat, it is more convenient to add it dissolved in the solvent used to form the metallated intermediate. The reaction is then stirred for 15 minutes to about 24 hours.
如果要分离亚胺,可用适当的溶剂稀释反应溶液,用水洗涤并减压浓缩成油状物。如想要纯化的产物,可将产物通过蒸馏,或如果合适,通过结晶来提纯。If the imine is to be isolated, the reaction solution can be diluted with an appropriate solvent, washed with water and concentrated to an oil under reduced pressure. If a purified product is desired, the product can be purified by distillation or, if appropriate, by crystallization.
把式(Ⅱ)化合物转化为苯甲醛的反应可用任何一种其强度能使C=N键水解的酸与亚胺一起搅拌来完成。在本发明的范围内,无机酸及有机酸等都被认为是足够强的酸。例如,甲磺酸、甲苯磺酸、三氟醋酸、苯甲酸、醋酸、氢氟酸、氢氯酸、氢溴酸、氢碘酸、硫酸、硝酸和磷酸都是合适的,最好用无机酸,而盐酸是特别优选的。The conversion of the compound of formula (II) to benzaldehyde is carried out by stirring with the imine any acid of such strength that it hydrolyzes the C=N bond. Within the scope of the present invention, inorganic acids as well as organic acids etc. are considered to be sufficiently strong acids. For example, methanesulfonic acid, toluenesulfonic acid, trifluoroacetic acid, benzoic acid, acetic acid, hydrofluoric acid, hydrochloric acid, hydrobromic acid, hydroiodic acid, sulfuric acid, nitric acid and phosphoric acid are suitable, preferably inorganic acids , while hydrochloric acid is particularly preferred.
在优选的方法中,含有产物(Ⅱ)的反应混合物可通过把酸加入反应混合物中直接水解。一般是把反应混合物加到酸的冷却溶液中,再让它温热到室温,反应混合物可通过诸如分析色谱来监测想要的苯甲醛的生成,但典型做法是把反应物搅拌大约1小时至大约24小时,然后用通常的技术诸如提取操作来分离产物。In a preferred method, the reaction mixture containing product (II) can be directly hydrolyzed by adding an acid to the reaction mixture. Typically, the reaction mixture is added to a cooled solution of the acid and allowed to warm to room temperature. The reaction mixture can be monitored for the formation of the desired benzaldehyde by, for example, analytical chromatography, but typically the reaction is stirred for about 1 hour to After about 24 hours, the product is then isolated by usual techniques such as extraction.
一种经改进的制备式(Ⅱ)化合物的方法,它包括在加碱之前先往反应物中加入催化量的一种有机胺,特别是当用烷基锂试剂作为碱时。加入催化量的有机胺可得到比不存在这种胺或加入等摩尔量的这种胺时都要高的产率。合适的有机胺是仲胺。代表性的胺类有二乙胺,二异丙胺,二环己基胺,哌啶,2,6-二甲基哌啶和2,2,6,6-四甲基哌啶。二异丙胺,二环己基胺和2,2,6,6-四甲基哌啶是特别合适的。催化量是指相对于每摩尔碳亚胺用大约0.01至大约0.03摩尔当量的有机胺,大约0.01至约0.15摩尔当量是合适的。通常用约0.01至0.1摩尔当量,它取决于所用的胺。例如对于二异丙基胺和2,2,6,6-四甲基哌啶,大约用0.01至大约0.05当量。An improved process for the preparation of compounds of formula (II) which comprises adding to the reactants a catalytic amount of an organic amine prior to the addition of the base, especially when an alkyllithium reagent is used as the base. Addition of a catalytic amount of an organic amine gives higher yields than either the absence of the amine or the addition of an equimolar amount of the amine. Suitable organic amines are secondary amines. Representative amines are diethylamine, diisopropylamine, dicyclohexylamine, piperidine, 2,6-dimethylpiperidine and 2,2,6,6-tetramethylpiperidine. Diisopropylamine, dicyclohexylamine and 2,2,6,6-tetramethylpiperidine are particularly suitable. Catalytic amounts mean about 0.01 to about 0.03 molar equivalents of organic amine per mole of carboimide, with about 0.01 to about 0.15 molar equivalents being suitable. Usually about 0.01 to 0.1 molar equivalent is used, depending on the amine used. For example, about 0.01 to about 0.05 equivalents are used for diisopropylamine and 2,2,6,6-tetramethylpiperidine.
本发明还有的另一个特征是提供一种改进的制备式(Ⅱ)化合物的方法,它包括制备式(Ⅲ)的碳亚胺的钠或钾盐,并把该产物与式(Ⅳ)化合物进行反应。例如,式(Ⅲ)的2-甲基苯基碳亚胺可用一种碱诸如正丁基锂或二异丙基胺化锂处理使形成锂盐,然后再用钠或钾碱或盐处理,通过金属交换反应形成所要的盐。烷氧化钠或钾,三氟醋酸钠或钾盐是代表性的碱/盐。这种碳亚胺盐与式(Ⅳ)化合物诸如7-苯基庚基氯化物的反应,比起用相应的碳亚胺的锂盐,可在较低的温度下进行烷基化反应,因而只有较少的副反应。用钾盐是特别合适的。Another feature of the present invention is to provide an improved method for the preparation of compounds of formula (II), which comprises the preparation of sodium or potassium salts of carboimides of formula (III), and combining the product with compounds of formula (IV) react. For example, 2-methylphenylcarboimide of formula (III) can be treated with a base such as n-butyllithium or lithium diisopropylamide to form a lithium salt followed by treatment with a sodium or potassium base or salt, The desired salt is formed by an exchange metal reaction. Sodium or potassium alkoxide, sodium or potassium trifluoroacetate are representative bases/salts. The reaction of this carboimide salt with a compound of formula (IV) such as 7-phenylheptyl chloride, compared with the lithium salt of the corresponding carboimide, can carry out the alkylation reaction at a lower temperature, so only Fewer side effects. Potassium salts are particularly suitable.
下列实施例解释如何制造和应用这些化合物以及有关的方法,它们构成了本发明。The following examples illustrate how to make and use the compounds, and related methods, which constitute the present invention.
实施例中所用的命名和缩写字是化学专业中通用的。除非特别注明,试剂是从市场买来的并且未经进一步的纯化即被使用。四氢呋喃如果是用作反应溶剂,可先用4A分子筛干燥,所有其它溶剂是以试剂级纯度从市场买来并且未经进一步的纯化即被使用。所有非水溶液中的反应都是在干燥氮气的保护下完成的。熔点是在Thomas-Hoover毛细管熔点测定仪上测定的,并且未经校正。液相色谱是在Whatman Partisil 5 ODS 3 RACⅡ型仪器上完成的。气相色谱分析是用DB-1 30m×0.53mm的毛细管柱完成的。IR光谱是用Perkin-Elmer Model283型红外光谱仪测定的。FT-IR是在Nicolet 6000 FT红外光谱仪上得到的。燃烧分析是用Perkin-Elmer 240 C型元素分析仪做的。除非特别注明,所有的HNMR(质子磁共振谱)是用Bruker Instruments WM400核磁共振仪在400兆周和氘代氯仿溶液中测定的,13CNMR谱是在100兆周测定的,化学位移从四甲基硅扫向低场,用ppm(δ)表示。The nomenclature and abbreviations used in the examples are commonly used in chemistry. Unless otherwise noted, reagents were purchased from commercial sources and used without further purification. If tetrahydrofuran was used as the reaction solvent, it was first dried over 4A molecular sieves, all other solvents were commercially available in reagent grade purity and used without further purification. All reactions in non-aqueous solutions were performed under a blanket of dry nitrogen. Melting points are determined on a Thomas-Hoover capillary melting point apparatus and are uncorrected. Liquid chromatography was performed on a Whatman Partisil 5 ODS 3 RAC II instrument. Gas chromatographic analysis was performed with a DB-1 30m×0.53mm capillary column. IR spectra were measured with a Perkin-Elmer Model 283 infrared spectrometer. FT-IR was obtained on a Nicolet 6000 FT infrared spectrometer. Combustion analysis was performed with a Perkin-Elmer Model 240 C Elemental Analyzer. Unless otherwise noted, all HNMR (proton magnetic resonance spectra) were measured with a Bruker Instruments WM400 NMR instrument at 400 megacycles and in deuterated chloroform solution, 13 CNMR spectra were measured at 100 megacycles, chemical shifts from Methyl silicon is swept downfield, expressed in ppm (δ).
对HNMR的注释如下:S,单重峰;d,双重峰;t,三重峰;br,宽峰;m,多重峰;J,偶合常数,以赫兹计。Annotations to HNMR are as follows: S, singlet; d, doublet; t, triplet; br, broad; m, multiplet; J, coupling constant in Hertz.
实施例1Example 1
1-溴-7-苯基庚烷的制备Preparation of 1-bromo-7-phenylheptane
在-5至0℃,于90分钟时间内把苄基氯化镁的溶液(750毫升,2M四氢呋喃溶液,1.5摩尔)加到搅拌着的1500毫升(0.15摩尔)0.1M Li2CuCl4和1,6-二溴己烷(456.8克,1.87摩尔,1.25当量)在四氢呋喃中所形成的溶液中,反应混合物在0℃搅拌90分钟,然后用2.0立升饱和氯化铵水溶液小心地处理。在处理过程中反应物内部温度保持在20℃以下。混合物在室温搅拌1小时并分层,有机层用20%氯化钠水溶液(4×500毫升)洗涤,干燥(硫酸镁),过滤,在45-50℃减压浓缩成一琥珀色油状物。用一支12英寸带真空夹套的Vigreux柱进行减压分馏提纯,得到所要的产物,为一无色油状物(198.2克,52%)。通过重蒸馏制备分析用的试样:沸点123-124℃(1.5mmHg);FT-IR(纯净液膜)3100-3000;3000-2800,2000-1700,1604,1496,748,699,644cm-1;HNMR(CDCl3,400MHz)δ7.29-7.16(m,5H),3.40(t,2H),2.60(t,2H),1.88-1.81(m,2H),1.63-1.60(m,2H),1.43-1.32(m,6H);13C NMR(CDCl3,100MHz).δ142.7,128.4,128.2,125.6,35.9,34.0,32.8,31.4,29.1,28.6,28.1.按C13H19Br分析计算值:C,61.91;H,7.50;Br,31.31;实验值:C,61.25;H,7.59;Br,31.47。A solution of benzylmagnesium chloride (750 ml, 2M in tetrahydrofuran, 1.5 moles) was added to stirred 1500 ml (0.15 moles) of 0.1M Li2CuCl4 and 1,6 at -5 to 0°C over a period of 90 minutes. - In a solution of dibromohexane (456.8 g, 1.87 mol, 1.25 equiv) in tetrahydrofuran, the reaction mixture was stirred at 0°C for 90 minutes, then carefully treated with 2.0 liters of saturated aqueous ammonium chloride. The internal temperature of the reactants was kept below 20°C during the treatment. The mixture was stirred at room temperature for 1 hour and the layers were separated. The organic layer was washed with 20% aqueous sodium chloride (4 x 500ml), dried (magnesium sulfate), filtered and concentrated under reduced pressure at 45-50°C to an amber oil. Purification by fractional distillation under reduced pressure on a 12 inch vacuum-jacketed Vigreux column gave the desired product as a colorless oil (198.2 g, 52%). Prepare samples for analysis by redistillation: boiling point 123-124°C (1.5mmHg); FT-IR (pure liquid film) 3100-3000; 3000-2800, 2000-1700, 1604, 1496, 748, 699, 644cm - 1 ; HNMR ( CDCl3 , 400MHz) δ7.29-7.16 (m, 5H), 3.40 (t, 2H), 2.60 (t, 2H), 1.88-1.81 (m, 2H), 1.63-1.60 (m, 2H) ), 1.43-1.32 (m , 6H); 13 C NMR (CDCl 3 , 100MHz) . Anal. Calcd. for Br: C, 61.91; H, 7.50; Br, 31.31; Found: C, 61.25; H, 7.59;
实施例2Example 2
7-氯-1-苯基庚烷的制备Preparation of 7-chloro-1-phenylheptane
a)1-溴-6-氯己烷a) 1-Bromo-6-chlorohexane
把1.6-己二醇(30公斤,254摩尔),48%氢溴酸(51公斤,302摩尔)和甲苯的混合物加热至回流,恒沸蒸馏除去水(34.5公斤),当蒸馏停止时把混合物冷却至20℃并用浓盐酸(69.9公斤)和水(60立升)形成的溶液提取。分相后把有机相通过重新加热和恒沸蒸馏除水进行干燥。把混合物冷却至65℃,加入二甲基甲酰胺(1.11公斤)。在45分钟内加入亚硫酰氯(31.4公斤,264摩尔)同时维持温度在65-68℃之间。把混合物在1.25小时内加热至109℃,然后冷却至20℃。再依次用20%氢氧化钠溶液(100立升)和水(2×150立升,1×100立升)洗涤。减压蒸去甲苯(400立升),即得到溴氯己烷的甲苯溶液(85.5公斤,分析测定其含量为55%W/W,收率93%)。1.6-Hexanediol (30 kilograms, 254 moles), the mixture of 48% hydrobromic acid (51 kilograms, 302 moles) and toluene is heated to reflux, azeotropic distillation removes water (34.5 kilograms), when distillation stops, the mixture Cool to 20°C and extract with a solution of concentrated hydrochloric acid (69.9 kg) and water (60 liters). After phase separation, the organic phase is dried by reheating and azeotropic distillation to remove water. The mixture was cooled to 65°C and dimethylformamide (1.11 kg) was added. Thionyl chloride (31.4 kg, 264 mol) was added over 45 minutes while maintaining the temperature between 65-68°C. The mixture was heated to 109°C over 1.25 hours and then cooled to 20°C. Then wash with 20% sodium hydroxide solution (100 liters) and water (2×150 liters, 1×100 liters) successively. Toluene (400 liters) was distilled off under reduced pressure to obtain a toluene solution of bromochlorohexane (85.5 kg, its content was determined to be 55% w/w by analysis, and the yield was 93%).
b)7-氯-1-苯基庚烷b) 7-Chloro-1-phenylheptane
在15℃,把四氯铜锂[四氢呋喃33立升,氯化锂(0.87公斤,19.3摩尔),氯化铜(1.4公斤,10.4摩尔)]的溶液加到苄基氯化镁在四氢呋喃中的溶液(160立升,1.86M溶液,298摩尔)中,并把混合物搅拌30分钟,在3小时内往其中加入溴氯己烷在甲苯中的溶液(85.5公斤溶液,分析测定其含量为55%W/W,47.1公斤,236摩尔),同时维持温度在15-20℃之间。继续搅拌1.25小时。在1小时内加入10%氯化铵溶液(263立升),同时维持温度在30℃以下。分相,有机相进一步用氯化铵溶液(170立升)和20%氯化钠溶液(3×197立升)洗涤。减压浓缩这有机溶液,残留一油状物(56.8公斤,HPLC分析测得其纯度为77%,校正后的收率为88%)。At 15°C, a solution of copper tetrachloride lithium [33 liters of tetrahydrofuran, lithium chloride (0.87 kg, 19.3 moles), copper chloride (1.4 kg, 10.4 moles)] was added to a solution of benzylmagnesium chloride in tetrahydrofuran ( 160 liters, 1.86M solution, 298 moles), and the mixture was stirred for 30 minutes, and a solution of bromochlorohexane in toluene (85.5 kg solution, analyzed to determine its content as 55% W/ W, 47.1 kg, 236 mol), while maintaining the temperature between 15-20°C. Stirring was continued for 1.25 hours. A 10% ammonium chloride solution (263 liters) was added over 1 hour while maintaining the temperature below 30°C. The phases were separated and the organic phase was further washed with ammonium chloride solution (170 liters) and 20% sodium chloride solution (3 x 197 liters). The organic solution was concentrated under reduced pressure to leave an oil (56.8 kg, 77% purity by HPLC analysis, 88% corrected yield).
实施例3Example 3
N-[(2-甲基苯基)亚甲基]-1,1-二甲基乙胺的制备Preparation of N-[(2-methylphenyl)methylene]-1,1-dimethylethylamine
搅拌下,将由邻-甲基苯甲醛(25克,0.21摩尔)和叔丁胺(27.75克,0.38摩尔)在甲苯(250毫升)中所形成的溶液在标准的Deam-stark条件下回流20小时。溶液蒸发成一油状物后进行减压蒸馏(沸点70-73℃,0.6mmHg),即得到33.9克(93%)产物:IR(纯净液膜)2980,1645,1605,1460,1375,1210,960,910cm-1;H NMR(400MHz,CDCl3)δ8.56(S,1H),7.86-7.83(m,1H);7.25-7.11(m,3H),2.46(S,3H),1.30(S,9H);13C NMR(CDCl3,100MHz)δ153.7,137.1,135.1,130.5,129.6,127.1,126.4,57.5,29.8,19.2,GCRT7.6分(DB-1,30m×0.53mm,程序升温:100℃5分钟,100-260℃。按每分钟升温15°的速率,在260℃保持12分钟)。A stirred solution of o-tolualdehyde (25 g, 0.21 mol) and tert-butylamine (27.75 g, 0.38 mol) in toluene (250 ml) was refluxed under standard Deam-stark conditions for 20 hours. The solution was evaporated into an oil and then distilled under reduced pressure (boiling point 70-73°C, 0.6mmHg) to obtain 33.9 grams (93%) of the product: IR (pure liquid film) 2980, 1645, 1605, 1460, 1375, 1210, 960 , 910cm -1 ; H NMR (400MHz, CDCl 3 ) δ8.56 (S, 1H), 7.86-7.83 (m, 1H); 7.25-7.11 (m, 3H), 2.46 (S, 3H), 1.30 (S , 9H); 13 C NMR (CDCl 3 , 100MHz) δ153.7, 137.1, 135.1, 130.5, 129.6, 127.1, 126.4, 57.5, 29.8, 19.2, GCRT7.6 points (DB-1, 30m×0.53mm, program Heating: 100°C for 5 minutes, 100-260°C. At a rate of 15°C per minute, keep at 260°C for 12 minutes).
实施例4Example 4
2-甲基苯甲醛二甲基腙的制备Preparation of 2-Methylbenzaldehyde Dimethylhydrazone
搅拌下,将由邻-甲基苯甲醛(25.0克,0.21摩尔)和1,1-二甲基肼(25.2克,0.42摩尔)所组成的溶液在甲苯(200毫升)中加热回流24小时。溶液减压浓缩,残余的油状物被减压蒸馏(51-60℃,0.2mmHg),得到标题产物(31.98克,94%):IR(纯净液膜)2950,2850,1580,1550,1455,1025,745cm-1;H NMR(CDCl3,400MHz)δ7.8-7.6(m,1H);7.4-7.3(m,1H),7.1-6.9(m,3H),2.9(S,6H);2.4(S,3H)。A stirred solution of o-toluene (25.0 g, 0.21 mol) and 1,1-dimethylhydrazine (25.2 g, 0.42 mol) in toluene (200 ml) was heated at reflux for 24 hours. The solution was concentrated under reduced pressure, and the residual oil was distilled under reduced pressure (51-60°C, 0.2 mmHg) to give the title product (31.98 g, 94%): IR (pure liquid film) 2950, 2850, 1580, 1550, 1455, 1025, 745cm -1 ; H NMR (CDCl 3 , 400MHz) δ7.8-7.6 (m, 1H); 7.4-7.3 (m, 1H), 7.1-6.9 (m, 3H), 2.9 (S, 6H); 2.4 (S, 3H).
实施例5Example 5
N-[(2-(8-苯基辛基)苯基)亚甲基]-1,1-二甲基乙胺的制备Preparation of N-[(2-(8-phenyloctyl)phenyl)methylene]-1,1-dimethylethylamine
搅拌下,向冷却到-5℃的二异丙胺(29.14克,0.289摩尔)在四氢呋喃(450毫升)中形成的溶液中加入正丁基锂(2.5M,114.3毫升,0.286摩尔),加入的速度应维持溶液的温度在10℃以下。加完后溶液在冷却下搅拌15分钟。往这溶液中加入N-[(2-甲基苯基)-亚甲基]-1,1-二甲基乙胺(50.0克,0.286摩尔)在四氢呋喃(65.0毫升)中的溶液,加入的速度应保持反应温度低于5℃。反应物在冷却下搅拌15分钟,然后很快地加入1-溴-7-苯基庚烷(72.9克,0.286摩尔)在四氢呋喃(75毫升)中的溶液,反应混合物在冷却下搅拌1小时,然后让它温热至室温并再搅拌14小时。通过气相色谱分析测定反应混合物中产物亚胺的含量(RT 19.8分,DB-1,30m×0.53mm,程序升温,100℃5分钟,100-260℃以每分15℃的速度升温,在260℃保持12分钟)。用水和二氯甲烷把反应混合物稀释,用水快速地洗涤有机混合物,并把溶液浓缩成一油状物,分离产物。油状物通过蒸馏提纯。Under stirring, to a solution of diisopropylamine (29.14 g, 0.289 mol) in tetrahydrofuran (450 ml) cooled to -5°C was added n-butyllithium (2.5M, 114.3 ml, 0.286 mol) at a rate of The temperature of the solution should be maintained below 10°C. After the addition was complete the solution was stirred for 15 minutes with cooling. To this solution was added a solution of N-[(2-methylphenyl)-methylene]-1,1-dimethylethylamine (50.0 g, 0.286 mol) in tetrahydrofuran (65.0 ml), and the added The rate should keep the reaction temperature below 5°C. The reaction mass was stirred under cooling for 15 minutes, then a solution of 1-bromo-7-phenylheptane (72.9 g, 0.286 mol) in tetrahydrofuran (75 ml) was added rapidly, and the reaction mixture was stirred under cooling for 1 hour. It was then allowed to warm to room temperature and stirred for an additional 14 hours. Determine the content of product imine in the reaction mixture by gas chromatography analysis (RT 19.8 minutes, DB-1, 30m × 0.53mm, temperature program, 100 ° C for 5 minutes, 100-260 ° C at a speed of 15 ° C per minute, at 260 °C for 12 minutes). The reaction mixture was diluted with water and dichloromethane, the organic mixture was washed rapidly with water, and the solution was concentrated to an oil, and the product was isolated. The oil was purified by distillation.
实施例6Example 6
N-[(2-(8-苯基辛基)苯基)亚甲基]-1,1-二甲基乙胺的制备Preparation of N-[(2-(8-phenyloctyl)phenyl)methylene]-1,1-dimethylethylamine
搅拌下,将由2-(8-苯基辛基)苯甲醛(10克,0.034摩尔)和叔丁胺(4.96克,0.068摩尔)在甲苯(100毫升)中形成的溶液在标准的Dean-Stark条件下加热回流16小时。溶液被蒸发成一油状物,并进行真空蒸馏(沸点260℃,0.15mmHg)即得到标题产物(11.1克,94%):GC RT 19.8分(DB-1,30m×0.53mm,程序升温,100℃5分钟,100-260℃以每分15℃的速度升温,在260℃保持12分钟);′H NMR(CDCl3,400MHz)δ8.58(S,1H),7.86(d,J=7.5Hz,1H);7.29-7.13(m,8H),2.79(t,J=7.5Hz,2H),2.58(t,J=7.5Hz,2H),1.59-1.51(m,12H),1.30(S,9H).A solution of 2-(8-phenyloctyl)benzaldehyde (10 g, 0.034 mol) and tert-butylamine (4.96 g, 0.068 mol) in toluene (100 ml) was stirred under standard Dean-Stark conditions. Heat to reflux for 16 hours. The solution was evaporated to an oil and vacuum distilled (boiling point 260°C, 0.15mmHg) to give the title product (11.1 g, 94%): GC RT 19.8 min (DB-1, 30m x 0.53mm, temperature programmed, 100°C 5 minutes, 100-260 ° C at a rate of 15 ° C per minute, keep at 260 ° C for 12 minutes); 'H NMR (CDCl 3 , 400 MHz) δ8.58 (S, 1H), 7.86 (d, J = 7.5 Hz , 1H); 7.29-7.13 (m, 8H), 2.79 (t, J = 7.5Hz, 2H), 2.58 (t, J = 7.5Hz, 2H), 1.59-1.51 (m, 12H), 1.30 (S, 9H).
实施例7Example 7
2-(8-苯基辛基)苯甲醛的制备Preparation of 2-(8-phenyloctyl)benzaldehyde
通过N-[(2-(8-苯基辛基)苯基)亚甲基]-1,1-二甲基乙胺的水解By hydrolysis of N-[(2-(8-phenyloctyl)phenyl)methylene]-1,1-dimethylethylamine
往N-[(2-(8-苯基辛基)苯基)亚甲基]-1,1-二甲基乙胺(0.51克,0.0146摩尔)在四氢呋喃(5毫升)中形成的溶液中加入10%盐酸(5毫升),并把混合物在室温搅拌15小时。加入二氯甲烷(10毫升)和水(10毫升),并分层。水层用二氯甲烷(1×15毫升)提取,合并的有机相,干燥(硫酸镁),过滤,减压浓缩得油状物(0.405克,HPLC分析测定其纯度为97.4%,校正后的收率为92%):IR(纯净液膜)2920,2880,1695,1600,1455cm-1;H NMR(CDCl3,400MHz)δ10.25(S,1H),7.80(d,d,1H,J=1.2和7.7Hz);7.45(m,1H),7.33-7.13(m,7H),2.98(t,2H,J=7.7Hz),2.58(t,2H,J=7.7Hz),1.58(m,4H),1.30(m,8H).To a solution of N-[(2-(8-phenyloctyl)phenyl)methylene]-1,1-dimethylethylamine (0.51 g, 0.0146 mol) in tetrahydrofuran (5 ml) 10% hydrochloric acid (5 ml) was added, and the mixture was stirred at room temperature for 15 hours. Dichloromethane (10ml) and water (10ml) were added and the layers were separated. The aqueous layer was extracted with dichloromethane (1×15 ml), the combined organic phases were dried (magnesium sulfate), filtered, and concentrated under reduced pressure to give an oil (0.405 g, the purity was 97.4% by HPLC analysis, the corrected yield rate of 92%): IR (pure liquid film) 2920, 2880, 1695, 1600, 1455cm -1 ; H NMR (CDCl 3 , 400MHz) δ10.25 (S, 1H), 7.80 (d, d, 1H, J = 1.2 and 7.7Hz); 7.45 (m, 1H), 7.33-7.13 (m, 7H), 2.98 (t, 2H, J = 7.7Hz), 2.58 (t, 2H, J = 7.7Hz), 1.58 (m , 4H), 1.30 (m, 8H).
实施例8Example 8
2-(8-苯基辛基)苯甲醛的制备Preparation of 2-(8-phenyloctyl)benzaldehyde
用一摩尔当量的含氮碱与1-溴-7-苯基庚烷反应。Reaction of 1-bromo-7-phenylheptane with one molar equivalent of nitrogenous base.
往搅拌着的,已冷却到-5℃的二异丙胺(29.14克,0.289摩尔)在四氢呋喃(450毫升)中形成的溶液中加入正丁基锂(2.5M,114.3毫升,0.286摩尔),加入的速度应使溶液的温度维持在10℃以下。加完后,溶液在冷却下搅拌15分钟,往这溶液中加入N-[(2-甲基苯基)-亚甲基]-1,1-二甲基乙胺(50.0克,0.286摩尔)在四氢呋喃(65.0毫升)中形成的溶液,加入的速度应使反应温度保持在5℃以下。反应物在冷却下搅拌15分钟,然后迅速地加入1-溴-7-苯基庚烷(72.9克,0.286摩尔)在四氢呋喃(75毫升)中的溶液。反应混合物在冷却下搅拌1小时,然后让它温热至室温并搅拌14小时。反应混合物用10%盐酸水溶液处理,在0℃搅拌1小时,然后在室温搅拌14小时。把反应混合物倾入二氯甲烷(700毫升)中并搅拌5分钟,分出有机层,水层用二氯甲烷(2×700毫升)提取,合并有机层,用10%盐酸(2×500毫升)洗涤,再用饱和食盐水洗涤(1×350毫升),然后减压浓缩,得一金黄色油状物。这粗产物通过Pope蒸馏器(100℃,0.2mmHg)蒸出低沸物,残余物用己烷(400毫升)处理并搅拌5分钟,让溶液沉降,并滗析,再重覆上述己烷处理两次,把合并的己烷洗液经过硅藻土垫过滤,并浓缩成一浅黄色油状物(72.5克,经HPLC分析测定其纯度为92.4%,校正后的收率为82%)。为分析的目的,可将小量试样进一步经库格管蒸馏提纯(250℃,0.1mmHg):IR(纯净液膜)2910,1695,1600,1450,1210,1190cm-1;H NMR(CDCl3,400MHz)δ10.25(S,1H),7.80(dd,1H,J=1.2和7.7Hz);7.45(m,1H),7.33-7.13(m,7H),2.98(t,2H,J=7.7Hz);2.58(t,2H,J=7.7Hz),1.58(m,4H),1.30(m,8H);13C NMR(CDCl3,100MHz)δ192.2,145.7,142.8,133.7,133.6,131.3,130.9,128.3,128.2,126.3,125.5,35.9,32.4,32.4,31.4,29.5,29.4,29.3,29.2,HPLC RT 5.8分(Whatman Partisil5 ODS 3 RACⅡ,4.6mm内径×10cm,2毫升/分7∶3 CH3CH∶H2O,在211nm用UV检测)。Add n-butyllithium (2.5M, 114.3 ml, 0.286 mol) to a stirred solution of diisopropylamine (29.14 g, 0.289 mol) in tetrahydrofuran (450 ml) cooled to -5°C, add The speed should be such that the temperature of the solution is maintained below 10°C. After the addition was complete, the solution was stirred under cooling for 15 minutes, and to this solution was added N-[(2-methylphenyl)-methylene]-1,1-dimethylethylamine (50.0 g, 0.286 mol) A solution in tetrahydrofuran (65.0 ml) was added at such a rate as to keep the reaction temperature below 5°C. The reaction was stirred with cooling for 15 minutes, then a solution of 1-bromo-7-phenylheptane (72.9 g, 0.286 mol) in tetrahydrofuran (75 ml) was added rapidly. The reaction mixture was stirred with cooling for 1 hour, then allowed to warm to room temperature and stirred for 14 hours. The reaction mixture was treated with 10% aqueous hydrochloric acid and stirred at 0°C for 1 hour, then at room temperature for 14 hours. The reaction mixture was poured into dichloromethane (700 ml) and stirred for 5 minutes, the organic layer was separated, the aqueous layer was extracted with dichloromethane (2×700 ml), the combined organic layers were washed with 10% hydrochloric acid (2×500 ml) ), washed with saturated brine (1×350 ml), and then concentrated under reduced pressure to obtain a golden yellow oil. The crude product was distilled off by Pope still (100°C, 0.2 mmHg) to remove low boilers, the residue was treated with hexane (400 ml) and stirred for 5 minutes, the solution was allowed to settle and decanted, and the above hexane treatment was repeated Twice, the combined hexane washes were filtered through a pad of celite and concentrated to a pale yellow oil (72.5 g, 92.4% pure by HPLC, 82% corrected yield). For the purpose of analysis, a small amount of sample can be further purified by Kuger tube distillation (250 ℃, 0.1mmHg): IR (pure liquid film) 2910, 1695, 1600, 1450, 1210, 1190cm -1 ; H NMR (CDCl 3 , 400MHz) δ10.25 (S, 1H), 7.80 (dd, 1H, J = 1.2 and 7.7Hz); 7.45 (m, 1H), 7.33-7.13 (m, 7H), 2.98 (t, 2H, J = 7.7Hz); 2.58 (t, 2H, J = 7.7Hz), 1.58 (m, 4H), 1.30 (m, 8H); 13 C NMR (CDCl 3 , 100MHz) δ192.2, 145.7, 142.8, 133.7, 133.6, 131.3, 130.9, 128.3, 128.2, 126.3, 125.5, 35.9, 32.4, 32.4, 31.4, 29.5, 29.4, 29.3, 29.2, HPLC RT 5.8 points (Whatman Partisil5 ODS 3 RACⅡ, 4.6mm inner diameter × 10cm, 2ml/ 7: 3 CH3CH: H2O with UV detection at 211nm).
实施例9Example 9
2-(8-苯基辛基)苯甲醛的制备Preparation of 2-(8-phenyloctyl)benzaldehyde
用两摩尔当量的亚胺和含氮碱以及一摩尔当量的1-氯-7-苯基庚烷。Two molar equivalents of imine and nitrogenous base and one molar equivalent of 1-chloro-7-phenylheptane were used.
在氮气保护下把二异丙基胺化锂在四氢呋喃中形成的溶液(15.4克,0.024摩尔)加到四氢呋喃(30毫升)中并冷却到-10℃。加入N-[(2-甲基苯基)-亚甲基]-1,1-二甲基乙胺(4.23克,0.024摩尔)在四氢呋喃(5毫升)中形成的溶液,并把混合物在-10℃搅拌20分钟。加入苯基庚基氯化物(2.77克,0.012摩尔)在四氢呋喃(5毫升)中的溶液并把反应混合物加热至58℃。3小时后气相色谱分析表明已不再有苯基庚基氯化物存留。把混合物冷却到0℃,加入稀盐酸(50毫升),加入的速度应使温度保持在25℃以下。把溶液重新加热到58℃并在此温度保持16小时。冷却到20℃后,加入二氯甲烷(100毫升),并分相。水相进一步用二氯甲烷(50毫升)提取,合并有机相,用水(100毫升)洗涤,用硫酸镁干燥后,过滤,蒸发溶剂,即得一油状产物(6.96克,HPLC分析测定其纯度为28.6%,校正后的产率为57%)。A solution of lithium diisopropylamide in tetrahydrofuran (15.4 g, 0.024 mol) was added to tetrahydrofuran (30 ml) under nitrogen and cooled to -10°C. A solution of N-[(2-methylphenyl)-methylene]-1,1-dimethylethylamine (4.23 g, 0.024 mol) in tetrahydrofuran (5 ml) was added, and the mixture was placed in- Stir at 10°C for 20 minutes. A solution of phenylheptyl chloride (2.77 g, 0.012 mol) in tetrahydrofuran (5 ml) was added and the reaction mixture was heated to 58°C. Gas chromatographic analysis after 3 hours indicated that no more phenylheptyl chloride remained. The mixture was cooled to 0°C and dilute hydrochloric acid (50ml) was added at such a rate as to keep the temperature below 25°C. The solution was reheated to 58°C and maintained at this temperature for 16 hours. After cooling to 20°C, dichloromethane (100 ml) was added and the phases were separated. The aqueous phase was further extracted with dichloromethane (50 ml), the organic phases were combined, washed with water (100 ml), dried with magnesium sulfate, filtered, and the solvent was evaporated to obtain an oily product (6.96 g, its purity was determined by HPLC analysis: 28.6%, and the corrected yield was 57%).
用上述反应条件,但是把反应混合物在室温搅拌20小时,代替原操作中的回流3小时,经校正后的收率为59%。Using the above reaction conditions, but stirring the reaction mixture at room temperature for 20 hours instead of reflux for 3 hours as in the original procedure, the corrected yield was 59%.
用上述反应条件,但是碳亚胺和胺碱相对于苯基庚基氯化物的用量是一摩尔当量,则得到的收率经校正后为42%。Using the above reaction conditions, but using one molar equivalent of carboimide and amine base relative to phenylheptyl chloride, a corrected yield of 42% was obtained.
实施例10Example 10
2-(8-苯基辛基)苯甲醛的制备Preparation of 2-(8-phenyloctyl)benzaldehyde
用钾交换锂作为碱性对离子/用不同的亚胺。Potassium was exchanged for lithium as a basic counterion/with a different imine.
a)在-10℃把N-[(2-甲基苯基)-亚甲基]-1,1-二甲基乙胺(5.00克,29毫摩尔)加到二异丙基胺化锂[28.5毫摩尔;由二异丙胺(4.0毫升,2.89克,29毫摩尔)和正丁基锂(2.5M,11.43毫升,28.5毫摩尔)所制得]在THF(50毫升)中形成的溶液中。在此温度搅拌75分钟后,加入叔丁醇钾(1.49M,19.2毫升,28.5毫摩尔)在THF中的溶液。再搅拌15分钟后,加入1-氯-7-苯基庚烷(3.77克,17.9毫摩尔)。反应物允许温热至室温并搅拌16小时。加入盐酸(6M,5毫升),并把混合物回流加热90分钟。分出水层,用己烷(2×200毫升)提取,合并有机相,用硫酸钠干燥,过滤,减压蒸发除去溶剂,即得一油状物(7.44克)。对它进行分析表明它含有65%W/W的苯基辛基苯甲醛(4.84克,16.5毫摩尔,92%)。a) Add N-[(2-methylphenyl)-methylene]-1,1-dimethylethylamine (5.00 g, 29 mmol) to lithium diisopropylamide at -10°C [28.5 mmol; prepared from diisopropylamine (4.0 mL, 2.89 g, 29 mmol) and n-butyllithium (2.5M, 11.43 mL, 28.5 mmol)] in THF (50 mL) . After stirring at this temperature for 75 minutes, a solution of potassium tert-butoxide (1.49M, 19.2 mL, 28.5 mmol) in THF was added. After stirring for a further 15 minutes, 1-chloro-7-phenylheptane (3.77 g, 17.9 mmol) was added. The reaction was allowed to warm to room temperature and stirred for 16 hours. Hydrochloric acid (6M, 5ml) was added and the mixture was heated at reflux for 90 minutes. The aqueous layer was separated and extracted with hexane (2 x 200ml). The combined organic phases were dried over sodium sulfate, filtered and the solvent was removed by evaporation under reduced pressure to give an oil (7.44g). Its analysis showed it to contain 65% w/w phenyloctylbenzaldehyde (4.84 g, 16.5 mmol, 92%).
b)用上述a)的操作程序,但用N-[(2-甲基苯基)-亚甲基]-异丙胺和N-[(2-甲基苯基)亚甲基]-正丁胺,得到以下结果:b) Using the procedure of a) above, but using N-[(2-methylphenyl)-methylene]-isopropylamine and N-[(2-methylphenyl)methylene]-n-butyl amines, the following results are obtained:
R3比率R 3 Ratio
亚胺取代基 亚胺:PHC 产率(%)Imine Substituent Imine:PHC Yield (%)
(ⅰ)叔丁基 1.6:1 92(ⅰ) tert-butyl 1.6:1 92
(ⅱ)异丙基 2.0:1 31(ii) Isopropyl 2.0:1 31
(ⅰ)正丁基 2.0:1 ~10(ⅰ) n-butyl 2.0:1 ~10
实施例11Example 11
2-(8-苯基辛基)苯甲醛的制备Preparation of 2-(8-phenyloctyl)benzaldehyde
用催化量的含氮碱/比较不同的亲电试剂。Using catalytic amounts of nitrogenous bases / comparing different electrophiles.
a)苯基庚基溴化物/苯基庚基碘化物a) Phenylheptyl Bromide/Phenylheptyl Iodide
ⅰ)在0℃,往N-[(2-甲基苯基)-亚甲基]-1,1-二甲基乙胺(5.0克,0.03摩尔)和N,N,N′,N′-四甲基乙二胺(3.31克,0.03摩尔)在四氢呋喃(40毫升)中形成的溶液中慢慢加入正丁基锂(2.5M,11.4毫升,0.03摩尔)。溶液搅拌另外30分钟,接着快速地加入1-溴-7-苯基庚烷(7.28克,0.03摩尔)在四氢呋喃(10毫升)中的溶液。让反应混合物温热至室温并继续搅拌15小时。用10%盐酸水溶液处理反应混合物,并搅拌30分钟。分层,往有机层中加入二氯甲烷(50毫升),有机相用饱和食盐水溶液(50毫升)洗涤。然后把有机相干燥(硫酸镁),并浓缩成一油状物,即产生2-(8-苯基辛基)苯甲醛(3.8克,45%):IR(纯净液膜)2920,2880,1695,1600,1455cm-1;H NMR(CDCl3,400MHz)δ10.25(S,1H),7.80(dd,1H,J=1.2和7.7Hz);7.45(m,1H),7.33-7.13(m,7H),2.98(t,2H,J=7.7Hz);2.58(t,2H,J=7.7Hz),1.58(m,4H),1.30(m,8H)。i) At 0°C, to N-[(2-methylphenyl)-methylene]-1,1-dimethylethylamine (5.0 g, 0.03 mol) and N,N,N',N' - To a solution of tetramethylethylenediamine (3.31 g, 0.03 mol) in tetrahydrofuran (40 ml) was slowly added n-butyllithium (2.5M, 11.4 ml, 0.03 mol). The solution was stirred for an additional 30 minutes, followed by the rapid addition of a solution of 1-bromo-7-phenylheptane (7.28 g, 0.03 mol) in tetrahydrofuran (10 ml). The reaction mixture was allowed to warm to room temperature and stirring was continued for 15 hours. The reaction mixture was treated with 10% aqueous hydrochloric acid and stirred for 30 minutes. The layers were separated, dichloromethane (50 ml) was added to the organic layer, and the organic phase was washed with saturated saline solution (50 ml). The organic phase was then dried (magnesium sulfate) and concentrated to an oil, yielding 2-(8-phenyloctyl)benzaldehyde (3.8 g, 45%): IR (clean liquid film) 2920, 2880, 1695, 1600, 1455cm -1 ; H NMR (CDCl 3 , 400MHz) δ10.25 (S, 1H), 7.80 (dd, 1H, J = 1.2 and 7.7Hz); 7.45 (m, 1H), 7.33-7.13 (m, 7H), 2.98 (t, 2H, J = 7.7Hz); 2.58 (t, 2H, J = 7.7Hz), 1.58 (m, 4H), 1.30 (m, 8H).
ⅱ)用(a)(ⅰ)的操作程序,但用1-碘-7-苯基庚烷代替1-溴-7-苯基庚烷,结果以34%的产率制备了2-(8-苯基辛基)苯甲醛。ii) Using the procedure of (a)(i), but substituting 1-iodo-7-phenylheptane for 1-bromo-7-phenylheptane, 2-(8 -phenyloctyl)benzaldehyde.
b)1-溴-7-辛基庚烷/1-氯-7-苯基庚烷b) 1-bromo-7-octylheptane/1-chloro-7-phenylheptane
ⅰ)把N-[(2-甲基苯基)亚甲基]-1,1-二甲基乙胺(2.8克,0.016摩尔)和2,2,6,6-四甲基哌啶(0.23克,0.0016摩尔)在四氢呋喃(10毫升)中形成的溶液冷却到-5℃。在40分钟内往这溶液中加入正丁基锂(1.6M,10毫升,0.016摩尔)并维持温度在-5℃。在-5℃快速地加入1-溴-7-苯基庚烷(3.4克,0.0133摩尔)在四氢呋喃(5毫升)中的溶液,这时反应物温度很快地升至40℃,冷却至室温后把反应混合物搅拌1小时,加入稀盐酸处理反应混合物,并在室温搅拌16小时。用通常的方法分离产物(5.0克,纯度75%,经校正后的收率96%)。i) N-[(2-methylphenyl)methylene]-1,1-dimethylethylamine (2.8 g, 0.016 mol) and 2,2,6,6-tetramethylpiperidine ( 0.23 g, 0.0016 mol) in tetrahydrofuran (10 ml) was cooled to -5°C. To this solution was added n-butyllithium (1.6M, 10ml, 0.016mol) over 40 minutes maintaining the temperature at -5°C. A solution of 1-bromo-7-phenylheptane (3.4 g, 0.0133 mol) in tetrahydrofuran (5 ml) was added rapidly at -5°C, at which time the temperature of the reaction rose rapidly to 40°C and cooled to room temperature After the reaction mixture was stirred for 1 hour, the reaction mixture was treated with dilute hydrochloric acid and stirred at room temperature for 16 hours. The product was isolated by the usual method (5.0 g, 75% purity, 96% corrected yield).
ⅱ)用(b)(ⅰ)的操作程序,但用1-氯-7-苯基庚烷代替1-溴-7-苯基庚烷,结果以87%的经校正后的收率制备了苯基辛基苯甲醛。ii) Using the procedure of (b)(i), but substituting 1-chloro-7-phenylheptane for 1-bromo-7-phenylheptane, prepared in 87% corrected yield Phenyloctylbenzaldehyde.
实施例12Example 12
2-(8-苯基辛基)苯甲醛的制备Preparation of 2-(8-phenyloctyl)benzaldehyde
变化不同含氮碱形成阴离子时的温度的影响Effect of varying temperature on the formation of anions by different nitrogenous bases
a)搅拌下,将N-[(2-甲基苯基)亚甲基]-1,1-二甲基乙胺(11.2克,0.064摩尔)和2,2,6,6-四甲基哌啶(0.9克,0.0064摩尔)在四氢呋喃(40毫升)中形成的溶液冷却到-5℃。在60分钟内通过一个注射泵往这溶液中加入正丁基锂(1.6M,40毫升,0.064摩尔),加入的速度应使温度维持在0℃以下。把反应混合物搅拌30分钟,然后迅速地加入1-氯-7-苯基庚烷(11.23克,0.053摩尔)在四氢呋喃(20毫升)中的溶液,反应混合物在50-55℃加热两小时。把反应混合物冷却到40℃并通过慢慢加入稀盐酸(100毫升盐酸用300毫升水稀释)使反应终止。混合物在50-60℃加热2.5小时完成水解反应。混合物冷却到室温,分出有机相,水相用己烷(100毫升)提取。合并有机提取液,用水(100毫升)洗涤。提取液在硫酸镁上干燥,过滤后用己烷洗涤滤饼。在减压下把有机溶液浓缩,即得到2-(8-苯基辛基)苯甲醛,为一油状物(14.5克,HPLC分析测得其纯度为69.3%,经校正后的产率为87%)。a) N-[(2-methylphenyl)methylene]-1,1-dimethylethylamine (11.2 g, 0.064 mol) and 2,2,6,6-tetramethyl A solution of piperidine (0.9 g, 0.0064 mol) in tetrahydrofuran (40 ml) was cooled to -5°C. To this solution was added n-butyllithium (1.6M, 40ml, 0.064mol) via a syringe pump over 60 minutes at such a rate as to maintain the temperature below 0°C. The reaction mixture was stirred for 30 minutes, then a solution of 1-chloro-7-phenylheptane (11.23 g, 0.053 mol) in tetrahydrofuran (20 ml) was added rapidly and the reaction mixture was heated at 50-55°C for two hours. The reaction mixture was cooled to 40°C and quenched by the slow addition of dilute hydrochloric acid (100 ml of hydrochloric acid diluted with 300 ml of water). The mixture was heated at 50-60°C for 2.5 hours to complete the hydrolysis reaction. The mixture was cooled to room temperature, the organic phase was separated and the aqueous phase was extracted with hexane (100ml). The combined organic extracts were washed with water (100 mL). The extract was dried over magnesium sulfate, filtered and the filter cake was washed with hexane. Concentration of the organic solution under reduced pressure afforded 2-(8-phenyloctyl)benzaldehyde as an oil (14.5 g, 69.3% purity by HPLC, 87% after correction). %).
b)在1小时内往搅拌着的N-[(2-甲基苯基)亚甲基]-1,1-二甲基乙胺(21.0克,0.12摩尔)在四氢呋喃(75毫升)的溶液中加入正丁基锂(1.54M,78毫升,0.12摩尔),加入的速度应在冷却下维持温度在20-30℃之间。把混合物搅拌30分钟并迅速地加入1-氯-7-苯基庚烷(21.05克,0.1摩尔)在四氢呋喃(40毫升)中的溶液。反应混合物在50℃加热3小时,并通过慢慢加入稀盐酸使反应终止。把反应混合物在50-60℃加热2.5小时,完成水解反应。混合物被冷却至室温并分出有机相。水相用己烷提取,合并有机提取液,用水洗涤,用硫酸镁干燥,过滤后用己烷洗涤滤饼,减压浓缩有机溶液,即得2-(8-苯基辛基)苯甲醛,为一油状物(34.56克,HPLC分析测得其纯度为65.3%,经校正后的产率为77%)。b) To a stirred solution of N-[(2-methylphenyl)methylene]-1,1-dimethylethylamine (21.0 g, 0.12 mol) in tetrahydrofuran (75 ml) over 1 hour Add n-butyllithium (1.54M, 78ml, 0.12mol) to the mixture at such a rate as to maintain the temperature between 20-30°C under cooling. The mixture was stirred for 30 minutes and a solution of 1-chloro-7-phenylheptane (21.05 g, 0.1 mol) in tetrahydrofuran (40 ml) was added rapidly. The reaction mixture was heated at 50°C for 3 hours and quenched by the slow addition of dilute hydrochloric acid. The reaction mixture was heated at 50-60°C for 2.5 hours to complete the hydrolysis reaction. The mixture was cooled to room temperature and the organic phase was separated. The aqueous phase was extracted with hexane, the organic extracts were combined, washed with water, dried with magnesium sulfate, filtered and washed with hexane, and the organic solution was concentrated under reduced pressure to obtain 2-(8-phenyloctyl)benzaldehyde, It was an oil (34.56 g, 65.3% pure by HPLC analysis, 77% corrected yield).
c)用与(a)或(b)相同的操作程序,但改变含氮碱和形成阴离子的温度,得到以下的结果:c) Using the same procedure as (a) or (b), but varying the temperature of the nitrogenous base and anion formation, the following results are obtained:
胺 阴离子形成 溶液产率 杂质的分布Amines Anion formation Solution yield Impurity distribution
温度(℃) (%) (%PHE*) (%PHC**)Temperature (°C) (%) (%PHE * ) (%PHC ** )
ⅰ)(异丙基)2NH -5 55 7.2 17.3i) (isopropyl) 2 NH -5 55 7.2 17.3
ⅱ)(异丙基)2NH 25 94 1.8 0ii) (isopropyl) 2 NH 25 94 1.8 0
ⅲ)DCA+-5 48 8.6 14.9iii) DCA + -5 48 8.6 14.9
ⅳ)DCA+25 83 1.7 0.1iv) DCA + 25 83 1.7 0.1
ⅴ)TMP++-5 87 0.6 0.4v) TMP ++ -5 87 0.6 0.4
ⅵ)TMP++25 89 0.7 0.7ⅵ) TMP ++ 25 89 0.7 0.7
ⅶ)-- 0 45 ND NDⅶ)-- 0 45 ND ND
ⅷ)-- 25 77 ND NDⅷ)-- 25 77 ND ND
原注:Original note:
DCA+=环己基胺 PHE =苯基庚烯DCA + = Cyclohexylamine PHE = Phenylheptene
TMP++=四甲基哌啶 PHC =苯基庚基氯化物TMP ++ = Tetramethylpiperidine PHC = Phenylheptyl chloride
ND=未测定ND = not determined
d)用(a)或(b)的操作程序,但用1-溴-7-苯基庚烷,得到以下的结果:d) Using the procedure (a) or (b), but using 1-bromo-7-phenylheptane, the following results were obtained:
胺 阴离子形成 溶液产率 杂质的分布Amines Anion formation Solution yield Impurity distribution
温度(℃) (%) (%PHE·) (%)PHB*** Temperature (℃) (%) (%PHE · ) (%)PHB ***
ⅰ)(异丙基)2NH 0 89 ND NDi) (isopropyl) 2 NH 0 89 ND ND
ⅱ)TMP 25 96 ND NDⅱ) TMP 25 96 ND ND
原注:Original note:
PHB…=苯基庚基溴化物PHB … = phenylheptyl bromide
对于本专业熟练的技术人员来说显然还可以有许多这些实例的变化方式,本发明不限于这些实例,它包括下面的权利要求中所包含的所有变化方式。Many variations of these examples will be apparent to a person skilled in the art, and the invention is not limited to these examples, but includes all variations contained in the following claims.
Claims (22)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US85838492A | 1992-03-25 | 1992-03-25 | |
US858,384 | 1992-03-25 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN1078229A true CN1078229A (en) | 1993-11-10 |
Family
ID=25328179
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN93102980A Pending CN1078229A (en) | 1992-03-25 | 1993-03-25 | Process and intermediates for the preparation of 2-substituted benzaldehydes |
Country Status (16)
Country | Link |
---|---|
EP (1) | EP0643682A4 (en) |
JP (1) | JPH07507060A (en) |
KR (1) | KR950701310A (en) |
CN (1) | CN1078229A (en) |
AU (1) | AU3967993A (en) |
CA (1) | CA2132639A1 (en) |
FI (1) | FI944413L (en) |
HU (1) | HUT70046A (en) |
IL (1) | IL105128A0 (en) |
MA (1) | MA22843A1 (en) |
MX (1) | MX9301626A (en) |
NO (1) | NO943548L (en) |
SI (1) | SI9300146A (en) |
TW (1) | TW267157B (en) |
WO (1) | WO1993019033A1 (en) |
ZA (1) | ZA932049B (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108689861A (en) * | 2018-05-28 | 2018-10-23 | 吉林大学 | A kind of preparation method of N- ethyls -3- phenylpropylamines |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TWM317981U (en) | 2007-02-16 | 2007-09-01 | Int Bicycle Products Corp | Handlebar of transportation vehicle |
CN113620761B (en) * | 2021-08-26 | 2022-06-17 | 西北工业大学 | Preparation method for synthesizing aryl aldehyde compound by reducing aryl secondary amide or aryl secondary amide derivative with phenylsilane |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3637851A (en) * | 1967-10-18 | 1972-01-25 | Tenneco Chem | N - cycloalkyl-chlorobenzylidenimines and herbicidal compositions containing same |
US3466164A (en) * | 1968-03-29 | 1969-09-09 | Tenneco Chem | Process for the control of plant growth with n-(substituted benzylidene) alkyl amines |
US3910944A (en) * | 1974-11-20 | 1975-10-07 | Upjohn Co | Spiro(cyclopropane-1,4{40 -(4H)-s-triazolo-(4,3-a)(1,4)benzodiazepines) |
US4198349A (en) * | 1977-10-06 | 1980-04-15 | William H. Rorer, Inc. | Benzylideneaniline derivatives |
US4231962A (en) * | 1978-06-08 | 1980-11-04 | Ciba-Geigy Corporation | 3-Phenoxybenzylideneamines and 3-benzylbenzylideneamines |
US4874792A (en) * | 1985-04-19 | 1989-10-17 | Smithkline Beckman Corporation | Thiophenyl Alkanoic acids useful as leukotriene antagonists |
DE3535451A1 (en) * | 1985-10-04 | 1987-04-09 | Bayer Ag | METHOD FOR PRODUCING N-ALKYL-SUBSTITUTED HYDROXYLAMMONIUM CHLORIDES AND NEW N-ALKYL-SUBSTITUTED HYDROXYLAMMONIUM CHLORIDES |
-
1993
- 1993-03-22 IL IL105128D patent/IL105128A0/en unknown
- 1993-03-23 MA MA23138A patent/MA22843A1/en unknown
- 1993-03-23 ZA ZA932049A patent/ZA932049B/en unknown
- 1993-03-23 MX MX9301626A patent/MX9301626A/en unknown
- 1993-03-25 AU AU39679/93A patent/AU3967993A/en not_active Abandoned
- 1993-03-25 WO PCT/US1993/002803 patent/WO1993019033A1/en not_active Application Discontinuation
- 1993-03-25 HU HU9402743A patent/HUT70046A/en unknown
- 1993-03-25 JP JP5516838A patent/JPH07507060A/en active Pending
- 1993-03-25 EP EP93909170A patent/EP0643682A4/en not_active Withdrawn
- 1993-03-25 SI SI9300146A patent/SI9300146A/en unknown
- 1993-03-25 CN CN93102980A patent/CN1078229A/en active Pending
- 1993-03-25 CA CA002132639A patent/CA2132639A1/en not_active Abandoned
- 1993-06-15 TW TW082104786A patent/TW267157B/zh active
-
1994
- 1994-09-23 NO NO943548A patent/NO943548L/en unknown
- 1994-09-23 FI FI944413A patent/FI944413L/en not_active Application Discontinuation
- 1994-09-26 KR KR1019940703384A patent/KR950701310A/en not_active Application Discontinuation
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108689861A (en) * | 2018-05-28 | 2018-10-23 | 吉林大学 | A kind of preparation method of N- ethyls -3- phenylpropylamines |
CN108689861B (en) * | 2018-05-28 | 2021-02-26 | 吉林大学 | Preparation method of N-ethyl-3-phenylpropylamine |
Also Published As
Publication number | Publication date |
---|---|
HU9402743D0 (en) | 1994-12-28 |
MA22843A1 (en) | 1993-10-01 |
MX9301626A (en) | 1994-07-29 |
SI9300146A (en) | 1993-12-31 |
IL105128A0 (en) | 1994-01-25 |
KR950701310A (en) | 1995-03-23 |
TW267157B (en) | 1996-01-01 |
WO1993019033A1 (en) | 1993-09-30 |
CA2132639A1 (en) | 1993-09-30 |
NO943548D0 (en) | 1994-09-23 |
ZA932049B (en) | 1994-09-21 |
EP0643682A1 (en) | 1995-03-22 |
FI944413L (en) | 1994-11-23 |
JPH07507060A (en) | 1995-08-03 |
AU3967993A (en) | 1993-10-21 |
HUT70046A (en) | 1995-09-28 |
EP0643682A4 (en) | 1995-06-07 |
FI944413A0 (en) | 1994-09-23 |
NO943548L (en) | 1994-11-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN100349877C (en) | Preparation of aminopyrimidine compounds. | |
CN1079216A (en) | New enamides and method for making thereof and application | |
CN1628087A (en) | Production of alkenones | |
CN1072661C (en) | Novel substituted [2-(1-piperazinyl) ethoxy] methyl | |
CN1898255A (en) | Process for the preparation of pyridine derivatives | |
CN1191230C (en) | Preparation method of neuraminidase inhibitor RO-64-0796 | |
CN100340552C (en) | Process for preparing aryl ether | |
CN1282645C (en) | Process for preparing 3-hydroxy-N,1,6-trialkyl-4-oxo-1,4-dihydropyridine-2-carboxamide | |
CN1229347C (en) | Process for production of piperidine derivative fexofenadine | |
CN1082046C (en) | Process for producing 2 -(q -hydroxymethylphenyl) acetamide derivative and intermediate for the production thereof | |
CN1067394C (en) | Preparation of enantiopure indole carboxylic acids and their active derivatives | |
CN100340541C (en) | Process for preparation of alpha-hydroxycarboxylic acid amides | |
CN1095830C (en) | Process for preparing alkoxyiminoacetamide derivatives | |
CN1078229A (en) | Process and intermediates for the preparation of 2-substituted benzaldehydes | |
CN1179956C (en) | Intermediate for preparing substituted dioxazine | |
CN1244560C (en) | Method for preparing 4-haloalkyl nicotine nitriles | |
CN1343662A (en) | Preparing method of 4-substrated-1H-indole-3-glyoxyly amine | |
CN1195739C (en) | 2-sulfamoylbenzoic acid derivatives | |
CN1993369A (en) | A process for the synthesis of terbinafine and derivatives thereof | |
CN87107427A (en) | Substituted aminomethyl-5,6,7,8-tetralinoxoacetic acids, new intermediate products, their preparation process and their application as medicine | |
CN1185209C (en) | Preparation method of o-chloromethyl phenyl glyoxalic acid derivative | |
CN1028023C (en) | Preparation of glutaric acid derivatives | |
CN1103761C (en) | Process for producing 1 -substituted -hydantoins | |
CN1578760A (en) | Process for producing(2-nitrophenyl)acetonitrile derivative and intermediate therefor | |
CN1199729A (en) | Process to chloroketones using oxazolines |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C01 | Deemed withdrawal of patent application (patent law 1993) | ||
WD01 | Invention patent application deemed withdrawn after publication |